Clinic
UPMC Bedford Memorial
UPMC Bedford Memorial was paid $3.80M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is 99284, emergency room visit (serious) — 36% of everything it billed.
33Billing provider infoUPMC BEDFORD MEMORIAL
EVERETT, PA 15537
EVERETT, PA 15537
33aNPI1295724193assigned 10/14/2005
33bProvider typeEmergency Care Clinic/Center
28Total paid$3.80M
24GClaims149,627
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Pennsylvania
Rank by total paid#1 of 6
Median peer was paid$4K
This provider vs. median956×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 550 | $12K | |
| 2019 | 310 | $5K | |
| 2020 | 11,081 | $213K | |
| 2021 | 67,964 | $1.49M | |
| 2022 | 24,462 | $683K | |
| 2023 | 26,824 | $831K | |
| 2024incomplete | 18,436 | $562K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 10,872 | 10,431 | $1.35M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 5,981 | 5,844 | $499K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 2,313 | 2,209 | $374K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.0% | 1,478 | 1,460 | $113K |
| 80050 | General health panel | 3.0% | 2,422 | 2,396 | $113K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 4,604 | 4,357 | $107K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.5% | 659 | 635 | $97K |
| 80053 | Comprehensive metabolic panel | 2.4% | 9,291 | 8,565 | $91K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 2.3% | 2,902 | 2,690 | $86K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 13,747 | 12,058 | $66K |
| 80061 | Lipid panel | 1.5% | 4,973 | 4,927 | $59K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,921 | 2,695 | $50K |
171 more codes
| G0378 | Hospital observation service, per hour | <1% | 176 | $34K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 399 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,141 | $28K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 859 | $26K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,111 | $25K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 335 | $24K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,068 | $23K |
| 76830 | Ultrasound, transvaginal | <1% | 517 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,653 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 952 | $21K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 490 | $21K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 538 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,687 | $20K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 437 | $20K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 128 | $19K |
| 20610 | <1% | 641 | $17K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,321 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,343 | $16K |
| 87070 | <1% | 1,897 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 198 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,186 | $13K |
| 84484 | <1% | 1,775 | $13K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 258 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,946 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 420 | $9K |
| 84702 | <1% | 541 | $9K | |
| 83880 | <1% | 452 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 266 | $9K |
| 82607 | <1% | 828 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 399 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 634 | $8K |
| J3490 | Unclassified drugs | <1% | 1,512 | $8K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 115 | $7K |
| 81001 | <1% | 2,857 | $7K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 182 | $6K |
| 84439 | <1% | 859 | $6K | |
| 93971 | <1% | 113 | $6K | |
| 72110 | <1% | 312 | $6K | |
| 83735 | <1% | 1,245 | $6K | |
| 82728 | <1% | 532 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,957 | $6K |
| 87077 | <1% | 823 | $6K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 225 | $5K |
| 83605 | <1% | 851 | $5K | |
| 83690 | <1% | 1,315 | $5K | |
| 73610 | <1% | 293 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 143 | $5K |
| 76801 | <1% | 118 | $5K | |
| 86618 | <1% | 180 | $4K | |
| 83540 | <1% | 585 | $4K | |
| 73630 | <1% | 405 | $4K | |
| 80076 | <1% | 536 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 28 | $4K |
| 87040 | <1% | 339 | $4K | |
| 86803 | <1% | 207 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 283 | $4K |
| 73562 | <1% | 261 | $4K | |
| 87186 | <1% | 478 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 151 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 338 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 32 | $3K |
| 85610 | <1% | 1,138 | $3K | |
| 73130 | <1% | 253 | $3K | |
| 82043 | <1% | 371 | $3K | |
| 76770 | <1% | 74 | $3K | |
| 71250 | <1% | 47 | $3K | |
| 93017 | <1% | 63 | $3K | |
| 73030 | <1% | 192 | $3K | |
| 82803 | <1% | 99 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 90 | $3K |
| 85379 | <1% | 306 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 57 | $2K |
| 73110 | <1% | 212 | $2K | |
| 80081 | <1% | 29 | $2K | |
| 85730 | <1% | 410 | $2K | |
| 82746 | <1% | 238 | $2K | |
| 76536 | <1% | 41 | $2K | |
| 80329 | <1% | 151 | $2K | |
| 93976 | <1% | 26 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 56 | $2K |
| 84100 | <1% | 316 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,076 | $2K |
| 73564 | <1% | 100 | $2K | |
| 73502 | <1% | 121 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,042 | $2K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 17 | $1K |
| 83550 | <1% | 342 | $1K | |
| 81003 | <1% | 500 | $1K | |
| 82784 | <1% | 75 | $1K | |
| 83615 | <1% | 216 | $1K | |
| 84153 | <1% | 54 | $1K | |
| 86038 | <1% | 77 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 71 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 182 | $1K |
| 84550 | <1% | 194 | $1K | |
| 83970 | <1% | 27 | $1K | |
| 85652 | <1% | 414 | $1K | |
| 86140 | <1% | 464 | $1K | |
| 86850 | <1% | 161 | $977.76 | |
| 84703 | <1% | 106 | $969.89 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,912 | $966.13 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 55 | $950.65 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $949.39 |
| 72050 | <1% | 36 | $824.22 | |
| 76642 | <1% | 25 | $803.57 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $787.48 |
| 80074 | <1% | 15 | $727.88 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,040 | $722.47 |
| 86592 | <1% | 170 | $669.38 | |
| 82962 | <1% | 424 | $667.45 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $636.80 |
| 86376 | <1% | 77 | $597.27 | |
| 82950 | <1% | 95 | $584.86 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,127 | $582.37 |
| 87088 | <1% | 87 | $581.90 | |
| 86901 | <1% | 179 | $552.24 | |
| 86900 | <1% | 179 | $551.59 | |
| 86617 | <1% | 13 | $533.35 | |
| 74018 | <1% | 57 | $504.59 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 26 | $439.30 |
| 81025 | <1% | 151 | $425.29 | |
| 82550 | <1% | 66 | $391.28 | |
| 84403 | <1% | 13 | $388.80 | |
| 86800 | <1% | 24 | $383.85 | |
| 84146 | <1% | 15 | $331.37 | |
| 90715 | <1% | 27 | $330.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,334 | $327.68 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 45 | $299.09 |
| 82565 | <1% | 65 | $288.55 | |
| 72072 | <1% | 14 | $286.61 | |
| 94664 | <1% | 25 | $249.28 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,304 | $237.48 |
| 82570 | <1% | 41 | $199.89 | |
| 87205 | <1% | 54 | $195.81 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,072 | $189.01 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 695 | $188.64 |
| 73140 | <1% | 27 | $188.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 371 | $183.23 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 53 | $146.62 |
| 82248 | <1% | 19 | $144.79 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 176 | $119.20 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 848 | $112.57 |
| 82977 | <1% | 21 | $111.89 | |
| 80069 | <1% | 15 | $107.19 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 124 | $105.73 |
| 87081 | <1% | 87 | $104.70 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 528 | $78.38 |
| 84520 | <1% | 13 | $58.72 | |
| 82150 | <1% | 16 | $54.50 | |
| 84156 | <1% | 15 | $53.72 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 282 | $43.68 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,257 | $39.93 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 156 | $34.90 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 512 | $23.25 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $23.03 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 37 | $13.85 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 26 | $9.63 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 323 | $9.56 |
| J2704 | Injection, propofol, 10 mg | <1% | 264 | $9.30 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 403 | $7.84 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 366 | $5.00 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 344 | $4.59 |
| 83986 | <1% | 13 | $2.88 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 73 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 140 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 17 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 19 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 54 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 13 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 41 | $0.00 |
| 84311 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKLATT, MONICA (CFO)
| Provider | Location | Paid |
|---|---|---|
| UPMC Altoona | Altoona, PA | $19.67M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.